Trial · NCT06851078
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of days alive without delirium or coma | 14 days after randomization | |
| Secondary | Mortality in intensive care | At day 28 | |
| Secondary | Mortality in intensive care | At day 90 | |
| Secondary | Mortality in hospital | At day 28 | |
| Secondary | Mortality in hospital | At day 90 | |
| Secondary | Overall survival | At day 90 | |
| Secondary | Duration of mechanical ventilation | At day 28 | |
| Secondary | Length of stay in intensive care unit | Up to day 90 | |
| Secondary | Length of stay in hospital | Up to day 90 | |
| Secondary | Occurrence of epileptic seizures | Up to day 14 | From Day 1 to Day 14 (confirmed by EEG or tonic-clonic seizures) and/or occurrence of epileptic abnormalities (periodic epileptic discharges) |
| Secondary | Time between cessation of sedation and awakening | At day 90 | Defined by spontaneous eye opening, among patients not deceased under sedation |
| Secondary | Severity of cognitive impairment | At day 90 | Evaluated by a telephone survey using Telephone MoCA (Montreal Cognitive Assessment). The scores ranges from 0 to 30. A score of 26 or higher is typically considered normal. A score of 25 or lower may indicate cognitive impairment, such as mild cognitive impairment (MCI) or early-stage dementia. |
| Secondary | Severity of anxiety and depression | At day 90 | Assessed with HADS (Hospital Anxiety and Depression Scale) scale Score varies from 0 to 21 for each componant (Anxiety and depression) The higher the score, the more severe the anxiety or depression. |
| Secondary | Presence of post-traumatic stress (PTSD) | At day 90 | Assessed by IES-R (Impact of Event Scale Revisited) The total score can range from 0 to 88. Higher scores indicate greater trauma-related distress and a higher likelihood of experiencing PTSD symptoms. |
| Secondary | Quality of life scoring | At day 90 | Using EQ-5D-5L. It evaluates five dimensions : mobility, self-care, usual activities, pain/discomfort and anxiety/depression and each dimension has five levels : no problems, slight problems, moderate problems, severe problems and extreme problems. Answers are given on a 5-point scale by domain, the higher the score, the poorer the quality of life. |
| Secondary | Autonomy in daily life | At day 90 | Using Katz Index of Independence in Activities of Daily Living (ADL) The score varies from 0 to 6, the lower the score, the more dependent the person. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06851078/registered